Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy
2018 · Clinical Cancer Research · 353 citations
https://doi.org/10.1158/1078-0432.ccr-18-2795
J
Jenny Lee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
303
Papers
6.4K
Citations
38
h-index
92
i10-index
Jenny Lee is an academic researcher from Rosalind Franklin University of Medicine and Science. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research & Immunotherapy and Immune Responses. The author has an h-index of 38, co-authored 258 publications.
ORCID: 0000-0001-8844-3444Papers by this author
worksCirculating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
2015 · Oncotarget · 322 citations
https://doi.org/10.18632/oncotarget.5788
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
2020 · Nature Communications · 294 citations
https://doi.org/10.1038/s41467-020-15726-7
Barriers to advance care planning: a qualitative study of seriously ill Chinese patients and their families
2020 · BMC Palliative Care · 73 citations
https://doi.org/10.1186/s12904-020-00587-0
Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients
2017 · Biomarker Research · 42 citations
https://doi.org/10.1186/s40364-017-0112-9
The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models
2017 · Neoplasia · 36 citations
https://doi.org/10.1016/j.neo.2017.06.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat